Condia 2 mg (Tablet)
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Glimepiride |
| Company | Jenphar bangladesh ltd |
| Also available as |
Title
- Condia Tablet
Categories
- Medicine
- Diabetes Care
- Pharmaceutical
Description
- Adjunct to diet and exercise for lowering blood glucose
- Indicated for noninsulin dependent (Type II) diabetes mellitus (NIDDM)
- May be used concomitantly with metformin
- Indicated for use in combination with insulin
- Stimulates the release of insulin from pancreatic beta cells
- Decreases blood glucose concentration
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin and glucose uptake
- Hypoglycaemic action persists for 24 hours
- Initial dose is 1 mg once daily
Dimensions
- Tablet form
- Dosage range 1 to 4 mg daily
Color Options
- Not applicable
Functions
- Lowers blood glucose levels
- Stimulates insulin secretion from beta cells
- Improves sensitivity of beta cells to glucose stimulus
- Reduces hepatic glucose production
- Increases peripheral tissue sensitivity to insulin
Materials
- Sulfonylurea antidiabetic agent
Technical Specifications
- Tablet must be swallowed with sufficient amount of liquid
Design Elements
- Packaged in a secure, light-resistant container
Usability Features
- Dose adjustment based on glucose level monitoring
- Single daily dose
- Taken immediately before a substantial breakfast or first main meal
- Not to be skipped after taking the drug
- Secondary dosage adjustment as control of diabetes improves
- Changeover from other oral antidiabetics
Mode of Action
- Stimulates insulin release from pancreatic beta cells
- Dependent on glucose sensitivity of beta cells
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin and glucose uptake
Drug Interactions
- Potentiate hypoglycaemic action with certain drugs (e.g., ACE inhibitors, steroid hormones)
- Attenuate hypoglycaemic action with other drugs (e.g., calcium channel blockers, corticosteroids)
- Potential for masking symptoms of hypoglycaemic attack with certain drugs (e.g., beta-receptor blockers, clonidine)
Contraindications
- Not suitable for insulin dependent (Type I) diabetes mellitus
- Not for use in diabetic ketoacidosis or diabetic coma
- Hypersensitivity to Glimepiride or sulfonylureas
- Severe hepatic dysfunction
- Severe impairment of renal function
- Not for dialysis patients
Side Effects
- Hypoglycaemia
- Temporary visual impairment
- Nausea
- Vomiting
- Diarrhoea
- Abdominal pain
- Urticaria
- Fall in blood pressure
Pregnancy & Lactation
- Not to be taken during pregnancy
- Changeover to insulin necessary during pregnancy
- Not for breastfeeding women
Precautions & Warnings
- Initial weeks of treatment may increase risk of hypoglycaemia
- Carbohydrates (glucose or sugar) to promptly control hypoglycaemia
- Careful monitoring required
Overdose Effects
- Hypoglycaemia in case of overdosage
- Mild symptoms treated with oral glucose and adjustments in drug dosage or meal patterns
- Severe reactions requiring immediate hospitalization
- Continuous monitoring for at least 24 to 48 hours
Therapeutic Class
- Sulfonylureas
Storage Conditions
- Do not store above 30°C
- Keep away from light and out of reach of children